Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2025 11:03 ET | Source: Research and Markets

Non-Viral Transfection Reagents Market Industry Trends and Forecasts to 2035: Patents, Partnerships, and Big Pharma Initiatives Accelerate Non-Viral Transfection Reagents Market Growth

Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Non-Viral Transfection Method,...
September 26, 2025 09:00 ET | Source: Shape Therapeutics, Inc.

Shape Therapeutics Announces Multiple Oral Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress

Shape Therapeutics to present at the ESGCT 32nd congress on an RNA-targeting gene therapy for Parkinson's Disease and a novel CNS AAV capsid.
September 25, 2025 08:27 ET | Source: Research and Markets

Cancer Gene Therapy Market to More Than Double Over the Next 5 Years - Strategic Collaborations and Focus on Cost-Effective, Scalable Solutions Will Drive Market Expansion

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The cancer gene therapy market,...
September 25, 2025 07:01 ET | Source: Research and Markets

Gene Therapy: Global and Regional Market Forecasts (2025-2030) by Therapy Type, Vector Type, Technique Type and Disease Type

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global gene therapy market is projected...
September 24, 2025 16:06 ET | Source: uniQure Inc.

uniQure Announces $200 Million Proposed Public Offering

LEXINGTON, Mass. and AMSTERDAM, Sept. 24, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
September 24, 2025 10:07 ET | Source: Pluristyx, Inc.

Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions

Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
September 24, 2025 07:10 ET | Source: uniQure Inc.

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

~ Term of current $50 million debt outstanding extended from January 2027 to October 2030 ~ ~ Additional $100 million available subject to regulatory and financial milestones ~ ~ Additional $25...
September 18, 2025 07:19 ET | Source: Research and Markets

U.S. Cell & Gene Therapy Contract Research Organizations Market Report 2025-2033, with Profiles of Altasciences, Allucent, Labcorp, Linical, Medpace, QPS, Syneos Health, and ICON

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell & Gene Therapy Contract Research Organizations Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical,...
September 15, 2025 06:03 ET | Source: Ocugen

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

Upfront fees and near-term development milestone payments totaling up to $7.5 millionPotential sales milestones of $180 million or more in first 10 years of commercializationRoyalties equaling 25% of...
September 10, 2025 06:34 ET | Source: Research and Markets

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "United States Cystic Fibrosis Therapeutics Market to See Strong Growth Through 2033 - Driven by Gene Therapy and CFTR Innovation" report has been...